logo

中东和非洲胰岛素输液泵市场 - 增长、趋势、COVID-19 影响和预测（2022 - 2027 年）

中东和非洲胰岛素输液泵市场按产品（胰岛素泵、输液器和储液器）和地理位置进行细分。

Home Industry Reports Healthcare 中东和非洲胰岛素输液泵市场 - 增长、趋势、COVID-19 影响和预测（2022 - 2027 年）

市场快照

MEA Insulin Infusion Pumps Market Size
Study Period: 2018 - 2026
Base Year: 2021
CAGR: 0 %
MEA Insulin Infusion Pumps Market Major Players

Need a report that reflects how COVID-19 has impacted this market and its growth?

市场概况

  • 在预测期内，中东和非洲胰岛素输液泵市场的复合年增长率将达到 7%。胰岛素输注泵可替代传统的每日注射系统或胰岛素笔。
  • 胰岛素输液泵可减少血糖水平的大幅波动（疼痛减轻），并且比注射更准确地输送。使用泵时不需要安排用餐时间。

报告范围

中东和非洲胰岛素输液泵市场按产品（胰岛素泵、输液器和储液器）和地理位置进行细分。

Product (Value and Volume 2012-2024)
Insulin Pump
Infusion Set
Reservoir
Geography
Middle East & Africa (MEA)
Saudi Arabia (Value and Volume 2012-2024)
By Insulin Pump
By Infusion Set
By Reservoir
South Africa (Value and Volume 2012-2024)
By Insulin Pump
By Infusion Set
By Reservoir
Iran (Value and Volume 2012-2024)
By Insulin Pump
By Infusion Set
By Reservoir
Egypt (Value and Volume 2012-2024)
By Insulin Pump
By Infusion Set
By Reservoir
Oman (Value and Volume 2012-2024)
By Insulin Pump
By Infusion Set
By Reservoir
Rest of MEA (Value and Volume 2012-2024)
By Insulin Pump
By Infusion Set
By Reservoir

Report scope can be customized per your requirements. Click here.

主要市场趋势

中东和非洲地区的糖尿病患病率

  • 在过去的二十年中，糖尿病的患病率急剧增加。这是由于肥胖的患病率增加，而肥胖是糖尿病的主要危险因素。
  • 胰岛素领域的研发正在逐年增加，科学家们正试图为患者提供最好的分子，抑制最大的副作用并提高其效率。 
  • 尽管胰岛素用于治疗糖尿病已有 90 多年的历史，但在全球范围内，当今需要胰岛素的人中有一半以上仍然负担不起和/或无法获得它。1 型糖尿病患者需要胰岛素治疗，治疗的重点是用胰岛素、饮食和生活方式控制血糖水平，以预防并发症。
MEA Insulin Infusion Pumps Market Trends

埃及在中东和非洲胰岛素输液泵市场占有率最高

  • 埃及在中东和非洲胰岛素输液泵市场占有最高的市场份额，预计在预测期内也将达到 5% 的高复合年增长率。
  • 在埃及，为 1 型糖尿病患者购买基本胰岛素的费用估计为平均每月可支配收入的 57%。
MEA Insulin Infusion Pumps Market Growth

竞争格局

  • Animas 不得不退出胰岛素输液泵市场，因为该公司承认竞争加剧是其退出市场的原因。
  • 美敦力是市场领导者，预计在预测期内将保持其地位。
Medtronic, Roche, Ypsomed

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Drivers

    3. 4.3 Restraints

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Bargaining Power of Suppliers

      2. 4.4.2 Bargaining Power of Consumers

      3. 4.4.3 Threat of New Entrants

      4. 4.4.4 Threat of Substitute Products and Services

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 Product (Value and Volume 2012-2024)

      1. 5.1.1 Insulin Pump

      2. 5.1.2 Infusion Set

      3. 5.1.3 Reservoir

    2. 5.2 Geography

      1. 5.2.1 Middle East & Africa (MEA)

        1. 5.2.1.1 Saudi Arabia (Value and Volume 2012-2024)

          1. 5.2.1.1.1 By Insulin Pump

          2. 5.2.1.1.2 By Infusion Set

          3. 5.2.1.1.3 By Reservoir

        2. 5.2.1.2 South Africa (Value and Volume 2012-2024)

          1. 5.2.1.2.1 By Insulin Pump

          2. 5.2.1.2.2 By Infusion Set

          3. 5.2.1.2.3 By Reservoir

        3. 5.2.1.3 Iran (Value and Volume 2012-2024)

          1. 5.2.1.3.1 By Insulin Pump

          2. 5.2.1.3.2 By Infusion Set

          3. 5.2.1.3.3 By Reservoir

        4. 5.2.1.4 Egypt (Value and Volume 2012-2024)

          1. 5.2.1.4.1 By Insulin Pump

          2. 5.2.1.4.2 By Infusion Set

          3. 5.2.1.4.3 By Reservoir

        5. 5.2.1.5 Oman (Value and Volume 2012-2024)

          1. 5.2.1.5.1 By Insulin Pump

          2. 5.2.1.5.2 By Infusion Set

          3. 5.2.1.5.3 By Reservoir

        6. 5.2.1.6 Rest of MEA (Value and Volume 2012-2024)

          1. 5.2.1.6.1 By Insulin Pump

          2. 5.2.1.6.2 By Infusion Set

          3. 5.2.1.6.3 By Reservoir

  6. 6. MARKET INDICATORS

    1. 6.1 Type-1 Diabetes Population (2012-2024)

    2. 6.2 Type-2 Diabetes Population (2012-2024)

  7. 7. COMPETITIVE LANDSCAPE

    1. 7.1 COMPANY PROFILES

      1. 7.1.1 Medtronic

      2. 7.1.2 Insulet

      3. 7.1.3 Roche

      4. 7.1.4 Animas

      5. 7.1.5 Tandem

      6. 7.1.6 Ypsomed

      7. 7.1.7 Cellnovo

    2. 7.2 COMPANY SHARE ANALYSIS

      1. 7.2.1 Roche

      2. 7.2.2 Animas

      3. 7.2.3 Medtronic

      4. 7.2.4 Other Companies

  8. 8. MARKET OPPORTUNITIES AND FUTURE TRENDS

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The MEA Insulin Infusion Pumps Market market is studied from 2018 - 2026.

The MEA Insulin Infusion Pumps Market is growing at a CAGR of 0% over the next 5 years.

Medtronic, Roche, Ypsomed are the major companies operating in MEA Insulin Infusion Pumps Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!